Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events-Reference-Cited by-同舟云学术

Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events

Published:2009-06 Issue:6 Volume:29 Page:975-980
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Semb Anne G.¹,Ueland Thor¹,Aukrust Pål¹,Wareham Nicholas J.¹,Luben Robert¹,Gullestad Lars¹,Kastelein John J.P.¹,Khaw Kay-Tee¹,Boekholdt S. Matthijs¹

Affiliation:

1. From the Department of Rheumatology (A.G.S.), Diakonhjemmet Hospital, Research Institute for Internal Medicine (T.U., P.A.), Section of Clinical Immunology and Infectious Diseases (P.A.), and the Department of Cardiology (L.G.), Oslo University Hospital, Rikshospitalet, University of Oslo, Norway; MRC Epidemiology Unit (N.J.W.), Department of Public Health and Primary Care (R.L., K.-T.K.), Institute of Public Health, University of Cambridge, UK; the Department of Cardiology (S.M.B.), and the...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease

2. Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome

3. Serum Osteoprotegerin Levels Are Associated With the Presence and Severity of Coronary Artery Disease

4. Increased Osteoprotegerin Serum Levels in Men with Coronary Artery Disease

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of osteoprotegerin and RANKL levels and several cardiovascular risk scoring systems in acromegaly;Hormones;2023-11-20

2. Genetically predicted osteoprotegerin levels and the risk of cardiovascular diseases: A Mendelian randomization study;International Journal of Cardiology;2023-11

3. Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort;Bone Research;2023-10-20

4. Predicting Factors of Atherosclerosis in Children with Beta-Thalassemia Major;Iranian Journal of Pediatric Hematology & Oncology;2023-01-03

5. Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children;Frontiers in Endocrinology;2022-08-19